Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 129 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact129 DOIs

Add abstracts to 25 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact25 DOIs

Deposit reference lists for 12 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact12 DOIs

DOIs for this ISSN

Showing the top 5 of 615 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Dimethyl fumarate-associated lymphopenia: Risk factors and c… (10.1177/2055217315596994)	ORCID	41.57	45
2	Accuracy and precision of smartphone applications and commer… (10.1177/2055217316634754)	ORCID	40.84	42
3	No evidence of disease activity (NEDA) analysis by epochs in… (10.1177/2055217318760642)	ORCID	36.18	27
4	Randomized controlled trial of an e-learning designed behavi… (10.1177/2055217317734886)	ORCID	35.37	25
5	Noninvasive tongue stimulation combined with intensive cogni… (10.1177/2055217317690561)	ORCID	34.04	22
6	Experience with long-term rituximab use in a multiple sclero… (10.1177/2055217316672100)	ORCID	33.56	21
7	Multiple sclerosis epidemiology in Latin America: An updated… (10.1177/2055217317715050)	ORCID	33.56	21
8	The relationship between objective parameters of sleep and m… (10.1177/2055217315577828)	ORCID	33.06	20
9	Predicting optimal response to B-cell depletion with rituxim… (10.1177/2055217315623800)	ORCID	33.06	20
10	Effects of expiratory muscle strength training on maximal re… (10.1177/2055217317710829)	ORCID	33.06	20
11	Improved cognitive performance and event-related potential c… (10.1177/2055217317747626)	ORCID	33.06	20
12	Introducing a new method to assess vision: Computer-adaptive… (10.1177/2055217315596184)	ORCID	31.97	18
13	Identifying an important change estimate for the Multiple Sc… (10.1177/2055217315596993)	ORCID	31.97	18
14	Comparison of fingolimod and dimethyl fumarate in the treatm… (10.1177/2055217317725102)	ORCID	31.97	18
15	The efficacy of cladribine tablets in CIS patients retrospec… (10.1177/2055217317732802)	ORCID	31.97	18
16	Remotely-delivered cognitive remediation in multiple scleros… (10.1177/2055217315609629)	ORCID	31.38	17
17	Testing patient-reported outcome measurement equivalence in… (10.1177/2055217317728740)	ORCID	31.38	17
18	Epidemiology of neuromyelitis optica in Latin America (10.1177/2055217317730098)	ORCID	31.38	17
19	Safety and efficacy of rituximab as first- and second line t… (10.1177/2055217320973049)	ORCID	31.38	17
20	Heart rate variability is differentially altered in multiple… (10.1177/2055217317701317)	ORCID	30.76	16
21	Comparative efficacy and discontinuation of dimethyl fumarat… (10.1177/2055217317715485)	ORCID	30.76	16
22	Application of the Betty Neuman systems model in the nursing… (10.1177/2055217317726798)	ORCID	30.76	16
23	Serum Neurofilament Light Chain in NMOSD and Related Disorde… (10.1177/2055217317743098)	ORCID	30.76	16
24	Validation of the Brief International Cognitive Assessment f… (10.1177/2055217317748972)	ORCID	30.76	16
25	Skeletal muscle mitochondrial capacity in people with multip… (10.1177/2055217316678020)	ORCID	30.10	15
26	The relationship between fatigability and sleep quality in p… (10.1177/2055217316682774)	ORCID	30.10	15
27	Safety assessment of gadolinium-based contrast agents (GBCAs… (10.1177/2055217317704450)	Abstract ORCID	30.10	3
28	MS in self-identified Hispanic/Latino individuals living in… (10.1177/2055217317725103)	ORCID	30.10	15
29	A double-blind, placebo-controlled, single ascending-dose st… (10.1177/2055217317743097)	ORCID	30.10	15
30	Serum heat shock protein 70 levels as a biomarker for inflam… (10.1177/2055217318767192)	ORCID	30.10	15
31	Relapse Rate and MRI Activity in Young Adult Patients With M… (10.1177/2055217318778610)	ORCID	30.10	15
32	Long-term treatment with low dose naltrexone maintains stabl… (10.1177/2055217316672242)	ORCID	29.40	14
33	Relapsing optic neuritis and isolated transverse myelitis ar… (10.1177/2055217316675634)	ORCID	29.40	14
34	Lymphocyte subtypes in relapsing–remitting multiple sclerosi… (10.1177/2055217317702933)	ORCID	29.40	14
35	A comparison of multiple sclerosis disease activity after di… (10.1177/2055217317730096)	ORCID	29.40	14
36	Adherence to behavioural interventions in multiple sclerosis… (10.1177/2055217315585333)	ORCID	28.65	13
37	Treadmill walking exercise training and brain function in mu… (10.1177/2055217318760641)	ORCID	28.65	13
38	Effects of a DVD-delivered exercise intervention on physical… (10.1177/2055217315584838)	ORCID	27.85	12
39	Free kappa light chains in cerebrospinal fluid as a biomarke… (10.1177/2055217315620935)	ORCID	27.85	12
40	Finger and foot tapping as alternative outcomes of upper and… (10.1177/2055217316688930)	ORCID	27.85	12
41	Effects of vitamin D<sub>3</sub> in clinically isolated synd… (10.1177/2055217317727296)	ORCID	27.85	12
42	Enhanced disease reduction using clozapine, an atypical anti… (10.1177/2055217317698724)	ORCID	26.98	11
43	Cognitive and neuropsychiatric disorders among MS patients f… (10.1177/2055217317717508)	ORCID	26.98	11
44	Interferon beta-1b in treatment-naïve paediatric patients wi… (10.1177/2055217317747623)	ORCID	26.98	11
45	National estimates of self-reported sitting time in adults w… (10.1177/2055217318754368)	ORCID	26.98	11
46	Erythrocytes in multiple sclerosis – forgotten contributors… (10.1177/2055217316649981)	ORCID	26.03	10
47	Prevalence of multiple sclerosis in Latin America and its re… (10.1177/2055217316666407)	ORCID	26.03	10
48	Environmental factors influencing multiple sclerosis in Lati… (10.1177/2055217317715049)	ORCID	26.03	10
49	Movement measurements at home for multiple sclerosis: walkin… (10.1177/2055217317753465)	ORCID	26.03	10
50	Association of multiple sclerosis and sudden sensorineural h… (10.1177/2055217316652155)	ORCID	25.00	9